| scholarly article | Q13442814 |
| P2093 | author name string | Jack H Jhamandas | |
| Valeri Goncharuk | |||
| P2860 | cites work | Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor | Q22254249 |
| Identification and characterization of two G protein-coupled receptors for neuropeptide FF | Q24290374 | ||
| New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals | Q24290381 | ||
| AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1 | Q24291281 | ||
| Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity | Q24301144 | ||
| A human gene encoding morphine modulating peptides related to NPFF and FMRFamide | Q24317787 | ||
| A new peptidic ligand and its receptor regulating adrenal function in rats | Q24320408 | ||
| A prolactin-releasing peptide in the brain | Q24321134 | ||
| Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor | Q28198401 | ||
| Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists | Q28202772 | ||
| In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist | Q28245009 | ||
| KiSS-1 and GPR54 at the pituitary level: overview and recent insights | Q28298398 | ||
| Functional characterization of a human receptor for neuropeptide FF and related peptides | Q28363833 | ||
| Cardiovascular effects induced by the stimulation of neuropeptide FF receptors in the dorsal vagal complex: an autoradiographic and pharmacological study in the rat | Q28564682 | ||
| Neuropeptide FF and neuropeptide VF inhibit GABAergic neurotransmission in parvocellular neurons of the rat hypothalamic paraventricular nucleus | Q28571443 | ||
| Centrally administered neuropeptide FF inhibits arginine vasopressin release in conscious rats | Q28575237 | ||
| Neuropeptide FF reduces food intake in rats | Q28576905 | ||
| Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception | Q28577654 | ||
| Central administration of neuropeptide FF (NPFF) causes increased neuronal activation and up-regulation of NPFF gene expression in the rat brainstem | Q28578340 | ||
| Combinatorial lead optimization of a neuropeptide FF antagonist. | Q30665667 | ||
| Neuropeptide changes in the suprachiasmatic nucleus in primary hypertension indicate functional impairment of the biological clock | Q31912182 | ||
| Characterization of the potent gonadotropin-releasing activity of RF9, a selective antagonist of RF-amide-related peptides and neuropeptide FF receptors: physiological and pharmacological implications | Q34099107 | ||
| RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia | Q34249621 | ||
| Neuropeptide FF, a mammalian neuropeptide with multiple functions | Q34396784 | ||
| Prolactin-releasing peptides | Q35134682 | ||
| The expanding family of -RFamide peptides and their effects on feeding behaviour | Q35763148 | ||
| Structure-activity relationships of neuropeptide FF and related peptidic and non-peptidic derivatives. | Q36401803 | ||
| Recent advances in mammalian RFamide peptides: the discovery and functional analyses of PrRP, RFRPs and QRFP. | Q36405723 | ||
| Local origins of some GABAergic projections to the paraventricular and supraoptic nuclei of the hypothalamus in the rat | Q36696192 | ||
| Reflex control of magnocellular vasopressin and oxytocin secretion | Q36700372 | ||
| Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine | Q37555862 | ||
| Opioid-modulating properties of the neuropeptide FF system | Q37783966 | ||
| The action of FMRFamide (Phe-Met-Arg-Phe-NH2) and related peptides on mammals | Q39561814 | ||
| Rat NPFF(1) receptor-mediated signaling: functional comparison of neuropeptide FF (NPFF), FMRFamide and PFR(Tic)amide. | Q40313851 | ||
| Diagonal band projection towards the hypothalamic supraoptic nucleus: light and electron microscopic observations in the rat. | Q41306076 | ||
| Neuropeptide FF receptor 2 (NPFF2) is localized to pain-processing regions in the primate spinal cord and the lower level of the medulla oblongata | Q42167633 | ||
| Distribution of the neuropeptide FF1 receptor (hFF1) in the human hypothalamus and surrounding basal forebrain structures: immunohistochemical study | Q42462486 | ||
| Baroreflex control of heart rate by oxytocin in the solitary-vagal complex | Q42515774 | ||
| Involvement of oxytocin in the nucleus tractus solitarii on central cardiovascular control: interactions with glutamate | Q43130161 | ||
| Pressor and tachycardic responses to intrathecal administration of neuropeptide FF in anesthetized rats. | Q43239470 | ||
| Prolactin-releasing peptide effects in the rat brain are mediated through the Neuropeptide FF receptor | Q43263251 | ||
| Neuropeptide FF2 receptor distribution in the human brain. An immunohistochemical study | Q43516001 | ||
| Intracerebroventricular injection of neuropeptide FF, an opioid modulating neuropeptide, acutely reduces food intake and stimulates water intake in the rat. | Q43780983 | ||
| Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [(125I]EYF as selective radioligands | Q44209077 | ||
| Central administration of neuropeptide FF causes activation of oxytocin paraventricular hypothalamic neurones that project to the brainstem | Q44282894 | ||
| Prolactin releasing peptide has high affinity and efficacy at neuropeptide FF2 receptors | Q44329091 | ||
| Neuropeptide FF (NPFF) control of magnocellular neurosecretory cells of the rat hypothalamic paraventricular nucleus (PVN). | Q46975444 | ||
| Activation by systemic angiotensin II of neurochemically identified neurons in rat hypothalamic paraventricular nucleus | Q47750741 | ||
| Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli | Q47968993 | ||
| Distribution of 26RFa binding sites and GPR103 mRNA in the central nervous system of the rat. | Q48153550 | ||
| Activation of neuropeptide FF neurons in the brainstem nucleus tractus solitarius following cardiovascular challenge and opiate withdrawal | Q48332857 | ||
| Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system | Q48465502 | ||
| Neuropeptide FF distribution in the human and rat forebrain: a comparative immunohistochemical study | Q48600348 | ||
| Characteristics and distribution of endogenous RFamide-related peptide-1. | Q48768800 | ||
| Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat | Q50935490 | ||
| FMRF-amide and L-Arg-L-Phe increase blood pressure and heart rate in the anaesthetised rat by central stimulation of the sympathetic nervous system. | Q51716396 | ||
| Vasopressin (VP) and neuropeptide FF (NPFF) systems in the normal and hypertensive human brainstem | Q57821115 | ||
| Paraventricular nucleus of the human hypothalamus in primary hypertension: Activation of corticotropin-releasing hormone neurons | Q59449335 | ||
| Structure of a molluscan cardioexcitatory neuropeptide | Q67590978 | ||
| Elevation of arterial pressure in rats by two new vertebrate peptides FLFQPQRF-NH2 and AGEGLSSPFWSLAAPQRF-NH2 which are immunoreactive to FMRF-NH2 antiserum | Q69430330 | ||
| Immunohistochemical distribution and partial characterization of FLFQPQRFamidelike peptides in the central nervous system of rats | Q69752475 | ||
| Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndrome | Q71364563 | ||
| Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat | Q71895849 | ||
| A novel action of the newly described prolactin-releasing peptides: cardiovascular regulation | Q73505809 | ||
| In vitro and in vivo studies of dansylated compounds, the putative agonists and antagonists on neuropeptide FF receptors | Q81595456 | ||
| P304 | page(s) | 8 | |
| P577 | publication date | 2013-02-07 | |
| P1433 | published in | Frontiers in Endocrinology | Q27723680 |
| P1476 | title | Role of neuropeptide FF in central cardiovascular and neuroendocrine regulation | |
| P478 | volume | 4 |
| Q35208498 | Differential expression patterns of PQRFamide peptide and its two receptor genes in the brain and pituitary of grass puffer during the reproductive cycle |
| Q21131271 | Does Kisspeptin Belong to the Proposed RF-Amide Peptide Family? |
| Q35760102 | Editorial: A Comparative Survey of the RF-Amide Peptide Superfamily |
| Q38616292 | NPFFR2 Activates the HPA Axis and Induces Anxiogenic Effects in Rodents |
| Q34557551 | Neuropeptide FF increases M2 activation and self-renewal of adipose tissue macrophages. |
| Q35662308 | Npvf: Hypothalamic Biomarker of Ambient Temperature Independent of Nutritional Status |
Search more.